.RESEARCH HIGHLIGHT.06 August 2024.
A large randomized measured trial with cisgender females highlights the challenges of faithfulness to a day-to-day dental preexposure prophylaxis program as well as illustrates that twice-yearly treatment of lenacapavir can maintain helpful HIV protection levels over 6 months.